Michal Cola

Medgenics Inc (NASDAQ: GNMX), which recently changed its official name to Aevi Genomic Medicine, was seen up 28.3 percent Thursday after a new SEC filing revealed that seven company insiders, including CEO Michael Cola, have been buying shares of the company’s stock. Together, the seven...